Latest event summaries
Event summaries combining transcripts, slides, and related documents. Updated as new events are published.
- FY26 earnings and cash flow strengthened as FY27 growth and buy-back plans take shape.BOL
AGM 2026 presentation - Bullabulling targets first gold in 2028, backed by 6.2Moz resources and project funding.MI6
AGM 2026 presentation - H1 FY27 sales outlook weakens as sunscreen sales recover and 2027 product plans advance.ANO
AGM 2026 presentation - Restarted production and first export position output for uranium-market upside.LOT
AGM 2026 presentation - $1.1B BILL stake targets 2027 cash EPS accretion, with a path to full ownership in 2030.CPAY
M&A announcement - A A$6.40-per-share Scheme proposal followed a year of margin expansion and operating disruption.MYX
AGM 2026 - Monthly fully franked income remained central as shareholders backed director re-elections.PL8
AGM 2026 presentation - FY2026 earnings grew, while FY2027 distribution guidance hinges on Edge transaction approvals.ARF
AGM 2026 - FY26 growth supports FY27 targets and a Life Company transition by Dec 2027.NOL
AGM 2026 presentation - A$28.8M FY26 royalty revenue underpins dividends and expanded exploration.RHI
AGM 2026 presentation - Gonneville advances toward H1 CY28 FID as Kestrel expands copper-gold exploration upside.CHN
AGM 2026 presentation - FY26 growth and a $4b partnership goal anchor the outlook as Downtown development is deferred.PCT
AGM 2026 - Digital-credit growth hinges on disciplined STRC support, liquidity and returns above funding costs.MSTR
Investor update - Rare-disease and injectable growth prospects face NMN competition and a disappointing Parkinson's trial.NAGE
18th Annual Southwest IDEAS Conference - FY26 EBIT surged as SLS growth, capital discipline and AI-driven reuse shaped plans.SGM
AGM 2026 - Q3 profit and supply-chain growth lifted guidance amid concentration and liquidity risks.PKK
Q3 2026